NASDAQ: DCOY
Decoy Therapeutics Inc Stock Ownership - Who owns Decoy Therapeutics?

Insider buying vs selling

Have Decoy Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arnold C. HanishDirector2025-12-3015$0.64
$9.60Sell
Arnold C. HanishDirector2025-12-3012$0.64
$7.68Sell
Arnold C. HanishDirector2025-11-205,000$0.75
$3.74kBuy
Mark J. RosenblumExec VP Finance CFO2025-11-2020,000$0.80
$16.00kBuy

1 of 1

DCOY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DCOY insiders and whales buy or sell their stock.

DCOY Shareholders

What type of owners hold Decoy Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christoph H. Westphal141.77%8,310,759$5.67MInsider
Boston Foundation Inc37.53%2,200,000$1.50MInsider
Roderick MacKinnon7.36%431,277$294.13kInsider
Jonathan P. Northrup6.02%352,713$240.55kInsider
Barton Pk LLC1.71%100,000$68.20kInsider
John Sculley1.01%59,111$40.31kInsider
Thomas 1. Wessel0.97%57,064$38.92kInsider
David J. Arthur0.84%49,135$33.51kInsider
Scott Jordan0.54%31,609$21.56kInsider
Warberg Asset Management LLC0.48%28,000$19.10kInstitution

1 of 3

DCOY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DCOY0.67%99.33%Net BuyingNet Selling
ASBP48.63%51.37%Net Buying
MTNB1.45%98.55%
GRI2.12%97.88%
OGEN0.54%99.46%Net SellingNet Selling

Decoy Therapeutics Stock Ownership FAQ

Who owns Decoy Therapeutics?

Decoy Therapeutics (NASDAQ: DCOY) is owned by 1.35% institutional shareholders, 199.10% Decoy Therapeutics insiders, and 0.00% retail investors. Christoph H. Westphal is the largest individual Decoy Therapeutics shareholder, owning 8.31M shares representing 141.77% of the company. Christoph H. Westphal's Decoy Therapeutics shares are currently valued at $5.68M.

If you're new to stock investing, here's how to buy Decoy Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.